Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $14.05.
Current Consensus is
The current consensus among 3 investment analysts is to sell stock in Redcare Pharmacy. This Sell consensus rating has held steady for over two years.
Redcare Pharmacy NV owns and operates online pharmacies in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.